BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34376979)

  • 1. Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles.
    Chen R; Ni S; Chen W; Liu M; Feng J; Hu K
    Int J Nanomedicine; 2021; 16():5265-5279. PubMed ID: 34376979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers.
    Kutty RV; Feng SS
    Biomaterials; 2013 Dec; 34(38):10160-71. PubMed ID: 24090836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer.
    Kutty RV; Chia SL; Setyawati MI; Muthu MS; Feng SS; Leong DT
    Biomaterials; 2015 Sep; 63():58-69. PubMed ID: 26081868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Sadeghian-Rizi S
    Anticancer Agents Med Chem; 2018; 18(14):2017-2031. PubMed ID: 30205803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
    Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
    Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution.
    Ma M; Hao Y; Liu N; Yin Z; Wang L; Liang X; Zhang X
    Int J Nanomedicine; 2012; 7():3389-98. PubMed ID: 22848167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.
    Yuan Z; Yuan Y; Han L; Qiu Y; Huang X; Gao F; Fan G; Zhang Y; Tang X; He X; Xu K; Yin P
    Int J Nanomedicine; 2018; 13():7533-7548. PubMed ID: 30532537
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M
    Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells.
    Zuo R; Zhang J; Song X; Hu S; Gao X; Wang J; Ji H; Ji C; Peng L; Si H; Li G; Fang K; Zhang J; Jiang S; Guo D
    Int J Nanomedicine; 2021; 16():1587-1600. PubMed ID: 33664573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel pH-triggered biocompatible polymeric micelles based on heparin-α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer.
    Emami J; Kazemi M; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A
    Pharm Dev Technol; 2020 Apr; 25(4):492-509. PubMed ID: 31903817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy.
    Jadon RS; Sharma G; Garg NK; Tandel N; Gajbhiye KR; Salve R; Gajbhiye V; Sharma U; Katare OP; Sharma M; Tyagi RK
    Colloids Surf B Biointerfaces; 2021 Jul; 203():111760. PubMed ID: 33872827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of micellar-like terpolymer nanoparticles with reductively-cleavable cross-links and evaluation of efficacy in 2D and 3D models of triple negative breast cancer.
    Monteiro PF; Gulfam M; Monteiro CJ; Travanut A; Abelha TF; Pearce AK; Jerôme C; Grabowska AM; Clarke PA; Collins HM; Heery DM; Gershkovich P; Alexander C
    J Control Release; 2020 Jul; 323():549-564. PubMed ID: 32371266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide modified polymeric micelles specific for breast cancer cells.
    Mathews AS; Ahmed S; Shahin M; Lavasanifar A; Kaur K
    Bioconjug Chem; 2013 Apr; 24(4):560-70. PubMed ID: 23514428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
    Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
    Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
    Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
    Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells.
    Cai LL; Liu P; Li X; Huang X; Ye YQ; Chen FY; Yuan H; Hu FQ; Du YZ
    Int J Nanomedicine; 2011; 6():3499-508. PubMed ID: 22282676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEG-conjugated triacontanol micelles as docetaxel delivery systems for enhanced anti-cancer efficacy.
    Lu X; Fang M; Yang Y; Dai Y; Xu J; Zhao D; Lu Y; Chen X; Lu S; Li N
    Drug Deliv Transl Res; 2020 Feb; 10(1):122-135. PubMed ID: 31444736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed Co-delivery of tamoxifen and docetaxel using lipid-coated mesoporous silica nanoparticles for overcoming CYP3A4-mediated resistance in triple-negative breast cancer treatment.
    Wang Y; Cheng W; Zhu J; He L; Ren W; Bao D; Piao JG
    Biomed Pharmacother; 2024 Jan; 170():116084. PubMed ID: 38157645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.